Arkolith/Insider Trading/AXSM/Form 4

Maizel Ari

Chief Commercial OfficerAxsome Therapeutics, Inc. (AXSM) · full profile →Form 4 · filed Jan 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 21, 2026Sell(S)8K$184.44$1.4M0
Jan 21, 2026Option exercise(M)8K$70.73$530K8K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 21, 2026Option exercise(M)8K—$031K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-021377) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML